Repligen (RGEN) Net Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Repligen (RGEN) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 191.00 |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -482.00 |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 1,264.00 |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3,776.00 |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 209.00 |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 184.00 |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 22,769.00 |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -998.00 |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3,064.00 |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | -1,588.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -998.00 |
| Mar 31, 2026 | -1,312.00 |
| Dec 31, 2025 | -918.00 |
| Sep 30, 2025 | -1,223.00 |
| Jun 30, 2025 | -1,586.00 |
| Mar 31, 2025 | -1,950.00 |
| Dec 31, 2024 | -8,288.00 |
| Sep 30, 2024 | -1,922.00 |
| Jun 30, 2024 | -1,864.00 |
| Mar 31, 2024 | -3,100.00 |
| Dec 31, 2023 | -97.00 |
| Sep 30, 2023 | -349.00 |
| Jun 30, 2023 | -570.00 |
| Mar 31, 2023 | 453.00 |
| Dec 31, 2022 | 2,601.00 |
| Sep 30, 2022 | 1,774.00 |
| Jun 30, 2022 | 1,256.00 |
| Mar 31, 2022 | 966.00 |
| Dec 31, 2021 | 475.00 |
| Sep 30, 2021 | 912.00 |